FREM2
Basic information
Region (hg38): 13:38687077-38887131
Links
Phenotypes
GenCC
Source:
- Fraser syndrome 1 (Definitive), mode of inheritance: AR
- Fraser syndrome 2 (Moderate), mode of inheritance: AR
- Fraser syndrome (Supportive), mode of inheritance: AR
- renal agenesis, unilateral (Supportive), mode of inheritance: AD
- Fraser syndrome 1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Fraser syndrome 2; Cryptophthalmos, unilateral or bilateral, isolated | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 15838507; 18203166; 18000968; 18671281; 30802441 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (60 variants)
- Fraser syndrome 2 (5 variants)
- Isolated cryptophthalmia (3 variants)
- Fraser syndrome 2;Isolated cryptophthalmia (1 variants)
- Fraser syndrome 1 (1 variants)
- FREM2-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FREM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 727 | 20 | 754 | |||
missense | 446 | 24 | 23 | 495 | ||
nonsense | 29 | 38 | ||||
start loss | 1 | |||||
frameshift | 37 | 46 | ||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 3 | 43 | 5 | 51 | ||
non coding | 93 | 158 | 93 | 344 | ||
Total | 66 | 24 | 550 | 909 | 136 |
Highest pathogenic variant AF is 0.0000197
Variants in FREM2
This is a list of pathogenic ClinVar variants found in the FREM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-38687085-A-G | Fraser syndrome 2 | Benign (Jun 21, 2021) | ||
13-38687094-A-G | Fraser syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
13-38687101-G-T | Fraser syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
13-38687126-G-A | Fraser syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
13-38687152-T-C | Fraser syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
13-38687163-G-A | Fraser syndrome 2 | Likely benign (Jan 13, 2018) | ||
13-38687312-A-G | Fraser syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
13-38687345-A-G | Fraser syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
13-38687356-C-A | Likely benign (Oct 28, 2023) | |||
13-38687356-C-T | Likely benign (Dec 07, 2023) | |||
13-38687356-CG-C | Fraser syndrome 2 | Pathogenic (Apr 10, 2019) | ||
13-38687357-G-T | Inborn genetic diseases | Uncertain significance (Nov 13, 2023) | ||
13-38687358-G-T | Inborn genetic diseases | Uncertain significance (Nov 13, 2023) | ||
13-38687366-G-A | Inborn genetic diseases | Uncertain significance (May 14, 2024) | ||
13-38687368-G-A | Likely benign (Oct 07, 2023) | |||
13-38687374-C-T | Likely benign (Dec 23, 2022) | |||
13-38687382-G-A | Fraser syndrome 2 | Uncertain significance (Apr 10, 2022) | ||
13-38687382-G-T | Uncertain significance (Dec 22, 2022) | |||
13-38687383-G-C | Likely benign (May 19, 2023) | |||
13-38687386-A-G | Likely benign (Oct 18, 2023) | |||
13-38687396-A-G | Inborn genetic diseases | Uncertain significance (Jun 06, 2022) | ||
13-38687409-C-T | Fraser syndrome 2 • Isolated cryptophthalmia;Fraser syndrome 2 | Uncertain significance (Jul 02, 2022) | ||
13-38687410-A-G | Likely benign (Jun 16, 2023) | |||
13-38687425-G-A | Likely benign (Sep 22, 2023) | |||
13-38687428-C-G | not specified • Fraser syndrome 2 • Isolated cryptophthalmia;Fraser syndrome 2 | Benign/Likely benign (Jan 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FREM2 | protein_coding | protein_coding | ENST00000280481 | 24 | 198809 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.60e-11 | 1.00 | 125616 | 0 | 132 | 125748 | 0.000525 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.859 | 1835 | 1.73e+3 | 1.06 | 0.0000950 | 20721 |
Missense in Polyphen | 393 | 459.66 | 0.85498 | 5544 | ||
Synonymous | -1.48 | 727 | 678 | 1.07 | 0.0000376 | 6524 |
Loss of Function | 6.05 | 38 | 105 | 0.363 | 0.00000603 | 1236 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000879 | 0.000879 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000689 | 0.000686 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000523 | 0.000523 |
Other | 0.000492 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Extracellular matrix protein required for maintenance of the integrity of the skin epithelium and for maintenance of renal epithelia. May be required for epidermal adhesion. {ECO:0000269|PubMed:15838507}.;
- Disease
- DISEASE: Fraser syndrome 2 (FRASRS2) [MIM:617666]: A form of Fraser syndrome, an autosomal recessive disorder characterized by cryptophthalmos, cutaneous syndactyly, and urogenital abnormalities including renal agenesis or hypoplasia. Additional features include abnormalities of the larynx, ear malformations, and facial abnormalities. {ECO:0000269|PubMed:15838507}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.708
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 16.77
Haploinsufficiency Scores
- pHI
- 0.413
- hipred
- Y
- hipred_score
- 0.604
- ghis
- 0.479
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.838
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Frem2
- Phenotype
- pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; respiratory system phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype;
Zebrafish Information Network
- Gene name
- frem2b
- Affected structure
- blood island
- Phenotype tag
- abnormal
- Phenotype quality
- blistered
Gene ontology
- Biological process
- eye development;morphogenesis of an epithelium;cell communication;cell adhesion;heart development;embryonic digit morphogenesis;inner ear development
- Cellular component
- basement membrane;plasma membrane;integral component of membrane;extracellular exosome
- Molecular function
- metal ion binding